Therapeutic Effects of Mutian® Xraphconn on 141 Client-Owned Cats with Feline Infectious Peritonitis Predicted by Total Bilirubin Levels
暂无分享,去创建一个
[1] B. Koletzko,et al. Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524 , 2021, Viruses.
[2] W. Novicoff,et al. Unlicensed GS-441524-Like Antiviral Therapy Can Be Effective for at-Home Treatment of Feline Infectious Peritonitis , 2021, Animals : an open access journal from MDPI.
[3] O. Jarrett,et al. Rapid Resolution of Non-Effusive Feline Infectious Peritonitis Uveitis with an Oral Adenosine Nucleoside Analogue and Feline Interferon Omega , 2020, Viruses.
[4] N. Pedersen,et al. Antiviral treatment using the adenosine nucleoside analogue GS‐441524 in cats with clinically diagnosed neurological feline infectious peritonitis , 2020, Journal of veterinary internal medicine.
[5] M. Yuki,et al. A Clinical Investigation on Serum Amyloid A Concentration in Client-Owned Healthy and Diseased Cats in a Primary Care Animal Hospital , 2020, Veterinary sciences.
[6] J. Levy,et al. Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses , 2020, One Health.
[7] D. Addie,et al. Oral Mutian®X stopped faecal feline coronavirus shedding by naturally infected cats , 2020, Research in Veterinary Science.
[8] K. Hartmann,et al. Diagnosis of Feline Infectious Peritonitis: A Review of the Current Literature , 2019, Viruses.
[9] N. Pedersen,et al. Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis , 2019, Journal of feline medicine and surgery.
[10] T. Takano,et al. Antiviral activity of itraconazole against type I feline coronavirus infection , 2019, Veterinary Research.
[11] N. Pedersen,et al. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies , 2018, Veterinary Microbiology.
[12] T. Knowles,et al. Limitations of using feline coronavirus spike protein gene mutations to diagnose feline infectious peritonitis , 2017, Veterinary Research.
[13] N. Pedersen,et al. Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis , 2017, Journal of feline medicine and surgery.
[14] R. Neiger,et al. Usefulness of acute phase proteins in differentiating between feline infectious peritonitis and other diseases in cats with body cavity effusions , 2017, Journal of feline medicine and surgery.
[15] V. M. Baylor,et al. Polyprenyl Immunostimulant Treatment of Cats with Presumptive Non-Effusive Feline Infectious Peritonitis In a Field Study , 2017, Front. Vet. Sci..
[16] Yoshikazu Tanaka,et al. Feline coronavirus replication is affected by both cyclophilin A and cyclophilin B , 2017, The Journal of general virology.
[17] H. Thiel,et al. Feline Coronaviruses , 2016, Advances in Virus Research.
[18] K. Hartmann,et al. Clinical and laboratory features of cats with feline infectious peritonitis – a retrospective study of 231 confirmed cases (2000–2010) , 2016, Journal of feline medicine and surgery.
[19] M. Hudgens,et al. Frequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxis , 2015, AIDS.
[20] R. DeBiasi,et al. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir. , 2015, The Journal of infectious diseases.
[21] Yoshikazu Tanaka,et al. Molecular epidemiological study of feline coronavirus strains in Japan using RT-PCR targeting nsp14 gene , 2015, BMC Veterinary Research.
[22] Niels C Pedersen,et al. An update on feline infectious peritonitis: Diagnostics and therapeutics , 2014, The Veterinary Journal.
[23] D. Wolf,et al. High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation. , 2014, The Journal of infectious diseases.
[24] T. Takano,et al. Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo , 2013, Antiviral Research.
[25] Yoshikazu Tanaka,et al. Suppression of Coronavirus Replication by Cyclophilin Inhibitors , 2013, Viruses.
[26] U. Jeffery,et al. Positive predictive value of albumin: globulin ratio for feline infectious peritonitis in a mid-western referral hospital population , 2012, Journal of feline medicine and surgery.
[27] K. Hartmann,et al. Randomized, Placebo Controlled Study of the Effect of Propentofylline on Survival Time and Quality of Life of Cats with Feline Infectious Peritonitis , 2011, Journal of veterinary internal medicine.
[28] Chao-Nan Lin,et al. Clinicopathological findings and disease staging of feline infectious peritonitis: 51 cases from 2003 to 2009 in Taiwan , 2011, Journal of Feline Medicine & Surgery.
[29] E. Thiry,et al. Feline infectious peritonitis. ABCD guidelines on prevention and management , 2009, Journal of Feline Medicine & Surgery.
[30] N. Pedersen. A review of feline infectious peritonitis virus infection: 1963–2008 , 2009, Journal of Feline Medicine & Surgery.
[31] K. Hartmann,et al. Treatment of cats with feline infectious peritonitis , 2008, Veterinary Immunology and Immunopathology.
[32] H. Egberink,et al. Effect of Feline Interferon‐Omega on the Survival Time and Quality of Life of Cats with Feline Infectious Peritonitis , 2007, Journal of veterinary internal medicine.
[33] Paltrinieri Saverio,et al. Critical Assessment of the Diagnostic Value of Feline α1-Acid Glycoprotein for Feline Infectious Peritonitis Using the Likelihood Ratios Approach , 2007 .